10.99
price down icon2.83%   -0.32
after-market After Hours: 10.30 -0.69 -6.28%
loading
Wave Life Sciences Ltd stock is traded at $10.99, with a volume of 866.64K. It is down -2.83% in the last 24 hours and down -23.94% over the past month. WAVE Life Sciences Ltd is unlocking the broad potential of RNA medicines also known as oligonucleotides, it targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISMTM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, splicing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
See More
Previous Close:
$11.31
Open:
$11.39
24h Volume:
866.64K
Relative Volume:
0.61
Market Cap:
$1.68B
Revenue:
$113.31M
Net Income/Loss:
$-57.51M
P/E Ratio:
-19.98
EPS:
-0.55
Net Cash Flow:
$-20.55M
1W Performance:
-4.77%
1M Performance:
-23.94%
6M Performance:
+85.96%
1Y Performance:
+133.33%
1-Day Range:
Value
$10.96
$11.46
1-Week Range:
Value
$10.57
$12.03
52-Week Range:
Value
$3.50
$16.73

Wave Life Sciences Ltd Stock (WVE) Company Profile

Name
Name
Wave Life Sciences Ltd
Name
Phone
617-949-2900
Name
Address
7 STRAITS VIEW, SINGAPORE
Name
Employee
268
Name
Twitter
@WAVELifeSci
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
WVE's Discussions on Twitter

Compare WVE with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
WVE
Wave Life Sciences Ltd
10.99 1.68B 113.31M -57.51M -20.55M -0.55
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
422.00 108.68B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
681.58 74.90B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
640.52 38.30B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
246.27 31.76B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
111.93 26.83B 3.30B -501.07M 1.03B -2.1146

Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades

Date Action Analyst Rating Change
Oct-16-24 Upgrade Raymond James Outperform → Strong Buy
Sep-27-24 Resumed JP Morgan Overweight
Sep-19-24 Initiated B. Riley Securities Buy
Sep-09-24 Initiated JP Morgan Overweight
May-15-24 Initiated Wells Fargo Overweight
Dec-19-23 Upgrade Leerink Partners Market Perform → Outperform
Jul-05-23 Initiated Raymond James Outperform
May-24-23 Downgrade Jefferies Buy → Hold
Dec-15-20 Resumed H.C. Wainwright Buy
Oct-23-20 Initiated RBC Capital Mkts Sector Perform
Dec-31-19 Downgrade SVB Leerink Outperform → Mkt Perform
Nov-01-19 Initiated Guggenheim Buy
Jul-15-19 Initiated Cowen Market Perform
Apr-17-19 Reiterated H.C. Wainwright Buy
Aug-07-18 Initiated Stifel Buy
Jul-23-18 Initiated H.C. Wainwright Buy
Mar-19-18 Reiterated Mizuho Buy
Feb-15-17 Initiated H.C. Wainwright Buy
Nov-10-16 Resumed Leerink Partners Outperform
Dec-07-15 Initiated JMP Securities Mkt Outperform
Dec-07-15 Initiated Jefferies Buy
Dec-07-15 Initiated Leerink Partners Outperform
Dec-07-15 Initiated Sun Trust Rbsn Humphrey Buy
View All

Wave Life Sciences Ltd Stock (WVE) Latest News

pulisher
04:54 AM

(WVE) Trading Advice - Stock Traders Daily

04:54 AM
pulisher
Jan 14, 2025

Wave Wants To Put The Joy Back Into Weight-Loss Drugs - News & Insights

Jan 14, 2025
pulisher
Jan 13, 2025

Is Wave Life Sciences (WVE) the Top Small Cap Stock to Buy with the Highest Upside Potential? - Yahoo Finance

Jan 13, 2025
pulisher
Jan 13, 2025

Wave Life Sciences Highlights Strategic Priorities and Expected 2025 Milestones Ahead of J.P. Morgan Presentation - GlobeNewswire

Jan 13, 2025
pulisher
Jan 13, 2025

Wave Life Sciences Advances Obesity Drug WVE-007, Reports Strong DMD Treatment Results - StockTitan

Jan 13, 2025
pulisher
Jan 13, 2025

Barclays PLC Has $1.31 Million Stock Position in Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat

Jan 13, 2025
pulisher
Jan 12, 2025

Top 10 Small Cap Stocks to Buy with the Highest Upside Potential - Insider Monkey

Jan 12, 2025
pulisher
Jan 12, 2025

WAVE Life Sciences (FRA:1U5) Cash From Discontinued Investi - GuruFocus.com

Jan 12, 2025
pulisher
Jan 12, 2025

Wave Life Sciences Ltd. (NASDAQ:WVE) Receives $22.22 Average Target Price from Brokerages - MarketBeat

Jan 12, 2025
pulisher
Jan 09, 2025

12 Best Growth Stocks Under $25 to Buy Now - Insider Monkey

Jan 09, 2025
pulisher
Jan 09, 2025

Is Wave Life Sciences Ltd. (WVE) the Best Growth Stock to Buy Now Under $25? - Yahoo Finance

Jan 09, 2025
pulisher
Jan 09, 2025

How to Take Advantage of moves in (WVE) - Stock Traders Daily

Jan 09, 2025
pulisher
Jan 08, 2025

Wave Life Sciences Is A Buy On Pipeline Prospects (WVE) - Seeking Alpha

Jan 08, 2025
pulisher
Jan 06, 2025

Wave Life Sciences (NASDAQ:WVE) Trading Down 4%Here's What Happened - MarketBeat

Jan 06, 2025
pulisher
Jan 02, 2025

Wave Life Sciences (NASDAQ:WVE) Stock Price Up 7.7%What's Next? - MarketBeat

Jan 02, 2025
pulisher
Dec 30, 2024

Learn to Evaluate (WVE) using the Charts - Stock Traders Daily

Dec 30, 2024
pulisher
Dec 29, 2024

Wave Life Sciences Ltd. (NASDAQ:WVE) Shares Purchased by Barclays PLC - MarketBeat

Dec 29, 2024
pulisher
Dec 29, 2024

Geode Capital Management LLC Increases Stock Holdings in Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat

Dec 29, 2024
pulisher
Dec 26, 2024

Wave Life Sciences (NASDAQ:WVE) Stock Price Down 2.6%Here's Why - MarketBeat

Dec 26, 2024
pulisher
Dec 24, 2024

Wave files clinical trial application for WVE-007 - BioWorld Online

Dec 24, 2024
pulisher
Dec 24, 2024

State Street Corp Has $19.03 Million Stock Holdings in Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat

Dec 24, 2024
pulisher
Dec 23, 2024

Wave Life Sciences Announces Submission of First Clinical Trial Application for WVE-007 (siRNA Targeting INHBE) in Obesity - The Manila Times

Dec 23, 2024
pulisher
Dec 23, 2024

Wave Life Sciences Announces Submission of First Clinical - GlobeNewswire

Dec 23, 2024
pulisher
Dec 23, 2024

Wave Life Sciences Advances Novel Obesity Drug WVE-007 Targeting INHBE Gene; Clinical Trials Set for 2025 - StockTitan

Dec 23, 2024
pulisher
Dec 20, 2024

WAVE Life Sciences (FRA:1U5) Other Long-Term Liabilities : €7.09 Mil (As of Sep. 2024) - GuruFocus.com

Dec 20, 2024
pulisher
Dec 20, 2024

WAVE Life Sciences (FRA:1U5) Dividend Payout Ratio : 0.00 (As of Sep. 2024) - GuruFocus.com

Dec 20, 2024
pulisher
Dec 19, 2024

Comprehensive Market Analysis of Latest Published 9 Rare Genetic Disorders Reports | DelveInsight - GlobeNewswire Inc.

Dec 19, 2024
pulisher
Dec 19, 2024

(WVE) Investment Analysis - Stock Traders Daily

Dec 19, 2024
pulisher
Dec 19, 2024

Y Intercept Hong Kong Ltd Has $242,000 Stock Holdings in Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat

Dec 19, 2024
pulisher
Dec 18, 2024

Wellington Management Group LLP Reduces Position in Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat

Dec 18, 2024
pulisher
Dec 18, 2024

Wave Life Sciences Ltd. (NASDAQ:WVE) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat

Dec 18, 2024
pulisher
Dec 16, 2024

Wave Life Sciences to Present at 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times

Dec 16, 2024
pulisher
Dec 14, 2024

WaVe Life Sciences' SWOT analysis: RNA editing pioneer's stock faces pivotal year - Investing.com Australia

Dec 14, 2024
pulisher
Dec 13, 2024

Point72 Asset Management L.P. Has $230,000 Holdings in Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat

Dec 13, 2024
pulisher
Dec 12, 2024

Neurological stocks rise and fall on clinical data; index down - BioWorld Online

Dec 12, 2024
pulisher
Dec 12, 2024

Fmr LLC Raises Stock Holdings in Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat

Dec 12, 2024
pulisher
Dec 12, 2024

Wave Life Sciences Ltd. (NASDAQ:WVE) Shares Purchased by Charles Schwab Investment Management Inc. - MarketBeat

Dec 12, 2024
pulisher
Dec 11, 2024

Can Sai Life Sciences ride the global CRDMO wave? A detailed IPO analysis - Dalal Street Investment Journal

Dec 11, 2024
pulisher
Dec 10, 2024

Jacobs Levy Equity Management Inc. Sells 262,075 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat

Dec 10, 2024
pulisher
Dec 05, 2024

Duchenne Muscular Dystrophy Pipeline Insights 2024: - openPR

Dec 05, 2024
pulisher
Dec 05, 2024

RTW Investments LP Makes New Investment in Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat

Dec 05, 2024
pulisher
Dec 05, 2024

486,023 Shares in Wave Life Sciences Ltd. (NASDAQ:WVE) Acquired by Polar Asset Management Partners Inc. - MarketBeat

Dec 05, 2024
pulisher
Dec 04, 2024

Maven Securities LTD Purchases Shares of 850,000 Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat

Dec 04, 2024
pulisher
Dec 03, 2024

Cinctive Capital Management LP Has $2.92 Million Stake in Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat

Dec 03, 2024
pulisher
Dec 02, 2024

Baker BROS. Advisors LP Invests $2.82 Million in Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat

Dec 02, 2024
pulisher
Dec 02, 2024

Walleye Capital LLC Invests $4.94 Million in Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat

Dec 02, 2024
pulisher
Nov 30, 2024

WAVE Life Sciences (STU:1U5) Pre-Tax Income : €-130.19 Mil (TTM As of Sep. 2024) - GuruFocus.com

Nov 30, 2024
pulisher
Nov 30, 2024

WAVE Life Sciences (FRA:1U5) Financial Strength : 6 (As of Sep. 2024) - GuruFocus.com

Nov 30, 2024
pulisher
Nov 28, 2024

Wave Life Sciences CEO Paul Bolno sells $750,000 in shares - Investing.com India

Nov 28, 2024
pulisher
Nov 27, 2024

Wave Life Sciences CEO Paul Bolno sells $750,000 in shares By Investing.com - Investing.com Canada

Nov 27, 2024

Wave Life Sciences Ltd Stock (WVE) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$30.75
price down icon 0.65%
$71.93
price down icon 0.75%
$19.03
price up icon 4.62%
$358.93
price down icon 2.04%
biotechnology ONC
$210.08
price up icon 2.31%
$111.93
price down icon 0.74%
Cap:     |  Volume (24h):